EUROPE - European institutional investors are buying customised OTC and securitised equity derivative products with a view to selling them on to high-net-worth and other retail customers, Greenwich Associates' research has found.
According to a study of 167 institutions, the proportion of European institutional investors active in customised OTC, securitised and hybrid derivative products increased from slightly more than 7...
To continue reading this article...
Join Professional Pensions
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, analysis and opinion from the industry
- Receive our in-depth monthly magazine in either print or digital format
- Access our Sustainable Investment Hub covering news and opinion from thought leaders in the ESG space
- Receive important and breaking news stories selected by the Editors in our daily newsletter
- Hear from industry experts and other forward-thinking leaders
- Receive a monthly members-only newsletter with exclusive opinion pieces from leading industry experts and a feature from the magazine in advance of its release date
